US2016030324A1PendingUtilityA1
Applications of surfactin in emulsifying composition and thereof
Est. expiryJul 31, 2034(~8 yrs left)· nominal 20-yr term from priority
A61K 8/19A61K 2800/413A61K 8/63A61K 2800/651A61K 8/735A61K 8/0241A61K 8/64A61Q 19/08A61K 8/88A61K 2800/805
44
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Surfactin is a biosurfactant produced by Bacillus subtilis and said surfactin is a natural cycloaliphatic peptide comprising a ring structure made of 7 amino acids, and said surfactin has various functions including anti-aging, anti-wrinkle, increasing skin penetration of cosmetic products (skin penetration agent), foaming agent and emulsifier.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1 . A method for preparation of a composition to improve skin penetration by using surfactin, wherein the composition comprises surfactin and pharmaceutically acceptable vehicles, excipients, diluents and adjuvants.
2 . The method as recited in claim 1 , wherein the surfactin is a cycloaliphatic peptide comprising a hepapeptide (L)Glu-(L)Leu-(D)Leu-(L)Val-(L)Asp-(D)Leu-(L)Leu linked to a β-hydroxy fatty acid, and the distribution of the fatty acids at the fatty acid end are as follows:
(1) iso-C13>3%;
(2) C13>0.65%;
(3) iso-C14>17%;
(4) C14<41%; and
(5) iso-C15<11%.
3 . The method as recited in claim 2 , wherein the distribution of the fatty acids at the fatty acid end of the surfactin are as follows:
(1) iso-C13>10%; (2) C13>25%; (3) iso-C14>35%; (4) C14<25%; and (5) iso-C15<3%.
4 . The method as recited in claim 3 , wherein the distribution of the fatty acids at the fatty acid end of the surfactin are as follows: (1) iso-C 13=11%; (2) C13=26%; (3) iso-C 14=37%; (4) C14=24%; and (5) iso-C15=2%.
5 . The method as recited in claim 1 , wherein the molecular weight of the surfactin is 1022 or 1036 Da.
6 . The method as recited in claim 1 , wherein the surfactin comprises its isomers.
7 . The method as recited in claim 1 , wherein the composition further comprises at least one of the following ingredients: alcohols, esters, complex polysaccharides, nut oils, and vitamins.
8 . The method as recited in claim 7 , wherein the alcohol comprises at least one of the following: C16-18 alcohols, butanediol, pentanediol, octanediol, glycerin, hexadecanol, stearyl alcohol, 1-Docosanol and propylene glycol.
9 . The method as recited in claim 7 , wherein the esters comprise at least one of the following: OLIVEM 1000, glycerol monostearate (GSM), isopropyl myristate (IPM), isopropyl palmitate (IPP) and triglycerides.
10 . The method as recited in claim 7 , wherein the complex polysaccharides comprise at least one of the following: xanthan gum, Tremella fuciformis polysaccharides, dextran polysaccharides, and Folium sennae seed polysaccharides.
11 . The method as recited in claim 7 , wherein the nut oil comprises at least one of the following: Argan oil, Kukui nut oil, avocado oil, wheat germ oil, and olive oil.
12 . The method as recited in claim 7 , wherein the vitamins comprise at least one of the following: vitamin A, vitamin B, vitamin C, vitamin E, vitamin F, and vitamin K.
13 . The method as recited in claim 1 , wherein the composition is used to promote skin penetration of cosmetic ingredients.
14 . The method as recited in claim 13 , wherein the cosmetic ingredient is dexamethasone.
15 . The method as recited in claim 13 , wherein the cosmetic ingredient is hyaluronic acid.
16 . The method as recited in claim 13 , wherein the cosmetic ingredient is gamma-polyglutamic acid.
17 . The method as recited in claim 13 , wherein the cosmetic ingredient is gold-nanoparticles.
18 . A method for preparation of an emulsifying composition using surfactin, wherein the composition comprises surfactin and pharmaceutically acceptable vehicles, excipients, diluents and adjuvants.
19 . The method as recited in claim 18 , wherein the surfactin is a cycloaliphatic peptide comprising a hepapeptide (L)Glu-(L)Leu-(D)Leu-(L)Val-(L)Asp-(D)Leu-(L)Leu linked to a β-hydroxy fatty acid, and the distribution of the fatty acids at the fatty acid end of the surfactin are as follows:
(1) iso-C13>3%;
(2) C13>0.65%;
(3) iso-C14>17%;
(4) C14<41%; and
(5) iso-C15<11%.
20 . The method as recited in claim 19 , wherein the distribution of the fatty acids at the fatty acid end of the surfactin are as follows:
(1) iso-C13>10%; (2) C13>25%; (3) iso-C14>35%; (4) C14<25%; and (5) iso-C15<3%.
21 . The method as recited in claim 20 , wherein the distribution of the fatty acids at the fatty acid end of the surfactin are as follows: (1) iso-C 13=11%; (2) C13=26%; (3) iso-C 14=37%; (4) C14=24%; and (5) iso-C15=2%.
22 . The method as recited in claim 18 , wherein the molecular weight of the surfactin is 1022 or 1036 Da.
23 . The method as recited in claim 18 , wherein the surfactin comprises its isomers.
24 . The method as recited in claim 18 , wherein the emulsifying composition further comprises at least one of the following ingredients: glycerol fatty acid esters, sorbitan fatty acid esters, sucrose fatty acid esters, propylene glycol fatty acid esters, and lecithin.
25 . The method as recited in claim 18 , wherein the emulsifying composition is for increasing foaming power.
26 . The method as recited in claim 18 , wherein the emulsifying composition is for increasing emulsification.
27 . The method as recited in claim 18 , wherein the emulsifying composition is for increasing the sense of smooth.Join the waitlist — get patent alerts
Track US2016030324A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.